Current Status and Future Prospects of Nutraceuticals in Prostate Cancer

作者: Sanjeev Shukla , Sanjay Gupta

DOI: 10.1007/978-94-007-2630-7_5

关键词:

摘要: Nutraceuticals are products derived from food sources that provide health benefits. Several natural dietary agents have been studied for their preventive and/or therapeutic effects against prostate cancer. Although most of the information on nutraceuticals and cancer is drawn epidemiologic case-control studies, clinical studies conducted so far not provided clear-cut results. The lack evidence-based limits use recommendations. In spite these limitations, field nutraceutical research continues to emerge as many nutritional tested potential in pre-clinical settings. significant medical economic impacts. This chapter highlights present status discusses future prospects strategies safe clinically beneficial.

参考文章(237)
H Mukhtar, N Ahmad, S Gupta, Prostate cancer chemoprevention by green tea. Seminars in Urologic Oncology. ,vol. 17, pp. 70- 76 ,(1999)
Mark C. Ledesma, Brittney Jung-Hynes, Travis L. Schmit, Raj Kumar, Hasan Mukhtar, Nihal Ahmad, Selenium and vitamin E for prostate cancer: post-SELECT (Selenium and Vitamin E Cancer Prevention Trial) status. Molecular Medicine. ,vol. 17, pp. 134- 143 ,(2011) , 10.2119/MOLMED.2010.00136
J Robak, R J Gryglewski, Bioactivity of flavonoids. Polish Journal of Pharmacology. ,vol. 48, pp. 555- 564 ,(1996)
Moyad Ma, Soy, disease prevention, and prostate cancer. Seminars in Urologic Oncology. ,vol. 17, pp. 97- 102 ,(1999)
Giuseppe Morgia, Christian Scifo, Marcella Renis, Venera Cardile, Alessandra Russo, Mario Motta, Mario Falsaperla, Gianmarco Silvestre, Emilio Imbriani, Involvement of HSP70 in resveratrol-induced apoptosis of human prostate cancer. Anticancer Research. ,vol. 23, pp. 4921- 4926 ,(2003)
Selwyn A. Broitman, John Wilkinson, Sonia Cerda, Steven K. Branch, Effects of Monoterpenes and Mevinolin on Murine Colon Tumor CT-26 in Vitro and its Hepatic “Metastases” in Vitro Advances in Experimental Medicine and Biology. ,vol. 401, pp. 111- 130 ,(1996) , 10.1007/978-1-4613-0399-2_9
Glenn Liu, Kurt Oettel, Howard Bailey, Lynn Van Ummersen, Kendra Tutsch, Mary Jane Staab, Dorothea Horvath, Dona Alberti, Rhoda Arzoomanian, Hamied Rezazadeh, James McGovern, Emily Robinson, David DeMets, George Wilding, Phase II trial of perillyl alcohol (NSC 641066) administered daily in patients with metastatic androgen independent prostate cancer. Investigational New Drugs. ,vol. 21, pp. 367- 372 ,(2003) , 10.1023/A:1025437115182